Back to search
FDAFDA · Food and drugs·Recall number D-0659-2026

Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01.

Published July 8, 2026 · Recall initiated: June 8, 2026

Summary

FDA records drug Class II recall D-0659-2026, published July 8, 2026 and initiated June 8, 2026. Recalling firm: Asclemed USA Inc.; Status: Ongoing; Reported quantity: N/A; Lot: Lot #: AE3102, 031926L01, 032026A01, Exp 11/30/2026; AE5052, 052026G01, Exp 04/30/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email if LIDOCAINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LIDOCAINE HYDROCHLORIDE
Manufacturer
Asclemed USA Inc.
Distributor
USA Nationwide
Lot
Lot #: AE3102, 031926L01, 032026A01, Exp 11/30/2026; AE5052, 052026G01, Exp 04/30/2028.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01. recalled?

Yes. FDA published recall D-0659-2026 on July 8, 2026. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LIDOCAINE HYDROCHLORIDE.